Drug releasing systems in cardiovascular tissue engineering. - Wikidata - awgldk - TriplyDB

Drug releasing systems in cardiovascular tissue engineering.

Drug releasing systems in cardiovascular tissue engineering.

http://www.wikidata.org/entity/Q37451635

about

Old Myths, New Concerns: the Long-Term Effects of Ascending Aorta Replacement with Dacron Grafts. Not All That Glitters Is Gold Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodelling and function of myocardial infarction bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis.Preliminary In Vivo Evaluation of a Hybrid Armored Vascular Graft Combining Electrospinning and Additive Manufacturing Techniques Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model Fabrication of small-diameter vascular scaffolds by heparin-bonded P(LLA-CL) composite nanofibers to improve graft patency.Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction Predifferentiated adult stem cells and matrices for cardiac cell therapy.Site-specific gene therapy for cardiovascular disease.Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction.Biomaterial applications in cardiovascular tissue repair and regeneration.Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications.State-of-the-Art Review of 3D Bioprinting for Cardiovascular Tissue Engineering.Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration CURRENT DEVELOPMENTS IN DRUG ELUTING DEVICES: Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis.A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes.Nitric oxide-eluting scaffolds and their interaction with smooth muscle cells in vitro.Stress-shielding, growth and remodeling of pulmonary artery reinforced with copolymer scaffold and transposed into aortic position.Marrow-isolated adult multilineage inducible cells embedded within a biologically-inspired construct promote recovery in a mouse model of peripheral vascular disease.Heparin-releasing scaffold for stem cells: a differentiating device for vascular aims.

P2860

Q28073731-2A24A393-4BFC-4FC7-ABAA-911AD3E8D558 Q35583202-4F58EEAF-6025-478A-BF68-5655350053A4 Q36205824-49B48D59-FF99-473F-BEBC-942C72554E1E Q36635967-B1B88747-29F5-44FA-B22D-3E529C2B8CF5 Q36837265-82ACB632-84D4-4707-8743-53E4FCDAE740 Q36925659-7E2E55F9-BC3D-47D3-9632-51BDECE42953 Q37662785-7EC0C201-9BD3-4C9C-8BAB-F510BBAB0ED1 Q37685810-3826ADD3-1100-4557-903E-F67BEFC1DE10 Q37703070-25E9DE8D-CA75-4F73-9859-819DBCE28443 Q37912067-D15426AC-F91E-4D05-8BDE-88E40759751C Q38048839-E3FB8ABA-B58E-4648-9420-879E2588AE46 Q38507265-F97AEB6E-AFCB-450D-AD4F-AF656483DBF6 Q38804863-5798582C-4E9D-4354-B7F6-8DBDA4689093 Q42114375-C6A8A5AC-FF54-4E30-BCA6-6C04C37C5797 Q42333763-534DB8EF-9119-48D8-A790-C228CED8B74D Q42914922-2200E6BF-6213-44C2-83D1-A60E4F5FCE48 Q46753596-0CE72059-1475-4016-9E5C-2CF7EFAF10A4 Q50766660-2D8C2B6A-5F25-42A7-B849-D34EE79523E0 Q51000153-14089E5A-4F1E-472B-AA77-5E6AFBE2E5F6 Q53734862-39C8FC09-277D-40B6-889C-67EB5FDBE5AA

P2860

Drug releasing systems in cardiovascular tissue engineering.

http://www.wikidata.org/entity/Q37451635

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drug releasing systems in cardiovascular tissue engineering.

@en

Drug releasing systems in cardiovascular tissue engineering.

@nl

type

label

Drug releasing systems in cardiovascular tissue engineering.

@en

Drug releasing systems in cardiovascular tissue engineering.

@nl

prefLabel

Drug releasing systems in cardiovascular tissue engineering.

@en

Drug releasing systems in cardiovascular tissue engineering.

@nl

P1433

Q37451635-4B3F6447-D1D7-4714-B508-CF34B259A3EC

P1476

Q37451635-984D5C76-82C8-40B4-93EE-2A94FA8807AD

P2093

Q37451635-0DBA19BD-FE05-4E0E-9B1F-88A38DC2A0AE

Q37451635-44899282-9731-46EB-9AFA-F2FBFFBADCBC

Q37451635-E2EBB36B-42DD-4DA4-8424-8BD5665D0560

P2860

Q37451635-002FA2AC-B602-43CA-8FEF-9F635ED17355

Q37451635-005002B4-A507-4F3F-9C0B-A37DBC8C3E2B

Q37451635-0131ECB0-C4CA-4EA8-BD1B-A8531A377B59

Q37451635-02A0AAC1-3F0C-4222-B774-E5D6B3EE5EFE

Q37451635-02E0BC14-C0A3-49DA-85FD-9098F78B28A9

Q37451635-0348C155-DA28-48D0-B09B-7B012555180C

Q37451635-03A65F4E-431E-429F-A96B-5ACAC5035979

Q37451635-03E0BF18-5BF6-452E-BE6D-34788DADD777

Q37451635-06637C86-8DDA-4C50-AE17-BD89D20C69DE

Q37451635-073D729A-B3B5-4554-9E8E-650EB17F6536

P304

Q37451635-0E01B7CB-197E-4EE8-9A83-A476D25ACE51

P31

Q37451635-4D152A2C-68B6-425F-B52B-4CD595673CA9

Q37451635-A569D2C3-680A-4633-B390-E3B034A27F6F

P356

Q37451635-F6CC7347-9B44-4532-9C8B-747E9F1FC053

P433

Q37451635-869BDEB3-4F60-43DA-8ACB-1A10FDDC4820

P478

Q37451635-B1E09E7D-364C-4A96-99C9-E17B9984F650

P50

Q37451635-25EF2F12-95BA-46C4-91DD-26CDFA15FCA7

Q37451635-6C0E4B70-31DD-4CC3-9D34-F5D8D9DEFA6D

Q37451635-C36C1E41-2402-4A78-A876-3ED57865F9A9

P577

Q37451635-9D2CAB5A-D43B-4201-984C-C1E1912F8EB7

P5875

Q37451635-585F2664-5ADD-42CB-95CE-28D129E54615

P698

Q37451635-D215440E-143C-4C99-BEBB-EF97FA586763

P921

Q37451635-394AC8C3-CC5C-4E93-8F98-52F9C5691C36

Q37451635-B3608299-8A6D-4027-9923-BC87006603C2

Q37451635-DA2E4F95-F11E-41BC-B17E-6605BC31F308

P932

Q37451635-D34BF7FC-94E7-46B8-9AB9-F8BEBF0E7EA5

P356

J.1582-4934.2008.00532.X

P1433

Journal of Cellular and Molecular Medicine

P1476

Drug releasing systems in cardiovascular tissue engineering.

@en

P2093

Cristiano Spadaccio

http://www.w3.org/2001/XMLSchema#string

Jorge A Genovese

http://www.w3.org/2001/XMLSchema#string

Yoshiya Toyoda

http://www.w3.org/2001/XMLSchema#string

P2860

Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution

Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters.

Biodegradable polyester, poly[alpha-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier.

A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity.

Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering.

Surface characteristics and biocompatibility of lactide-based poly(ethylene glycol) scaffolds for tissue engineering.

P304

422-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2008.00532.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Marcella Trombetta

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24310046

http://www.w3.org/2001/XMLSchema#string

P698

19379142

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

tissue engineering

biomedical investigative technique

P932

3822506

http://www.w3.org/2001/XMLSchema#string